Trade VIRBAC - VIRP CFD

Trading Conditions

• Type: CFD
• Spread: 2.22
• Long position overnight funding adjustment: -0.01661%
• Short position overnight funding adjustment: -0.00561%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: EUR
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: France
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 353.64
• Open: 353.64
• 1-Year Change: 13.83%
• Day's Range: 349.64 - 353.64

What is Virbac SA (VIRP)?

Virbac SA is a global animal health company specializing in the research, development, manufacturing, and marketing of veterinary pharmaceuticals and vaccines. The company offers products for companion animals, livestock, and aquaculture, addressing various health conditions and preventive care. Virbac operates internationally, providing solutions that support animal well-being and productivity. Its product range includes treatments for infectious diseases, parasitic infestations, and nutritional supplements. The company emphasizes innovation and scientific research to develop effective veterinary medicines. Virbac's activities also involve regulatory compliance and collaboration with veterinary professionals to promote animal health.

Virbac SA Stock Price Today: Live Overview

The price today is shaped by trading activity in Virbac SA, with the price spanning from €347.14 to €354.14 during the session. The current price is €352.86, with a daily change of 0%.

FAQ: Virbac SA (VIRP)

What is the current price of VIRP stock?

The current price is €352.86.

Does VIRP pay dividends?

Dividends are paid via cash distributions (if applicable).

Does VIRP have a formal corporate presence or regional headquarters in the UAE?

Virbac SA operates in the UAE through partners and does not have an official regional office or subsidiary.

What is VIRP best known for?

It is most famous for its veterinary pharmaceuticals and animal health products.

What assets are typically shown together with VIRP?

Commonly shown alongside VIRP: Assertio Holdings, Inc., Guangzhou Baiyunshan Pharma, AstraZeneca - USD